DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)

DGAP-Ad-hoc: Takeda Pharmaceutical Company Limited / Key word(s): Forecast Takeda Pharmaceutical Company Limited: Notice of the Revised Foreca...

Related Keywords

Osaka ,Japan ,United States ,Ryoko Matsumoto ,Christopher Oreilly ,Takeda Pharmaceutical Company Limited ,Takeda Pharmaceutical Company ,Revised Forecast ,Consolidated Financials ,Pharmaceutical Company Limited ,Full Year Consolidated Financials ,Fiscal Year Ending March ,Rare Genetics ,Plasma Derived Therapies ,